Antiviral target compound profile for pandemic preparedness.
Saved in:
| Title: | Antiviral target compound profile for pandemic preparedness. |
|---|---|
| Authors: | Demarest JF; INTREPID Alliance, Cambridge, MA, USA., Draghia-Akli R; INTREPID Alliance, Cambridge, MA, USA., Cihlar T; INTREPID Alliance, Cambridge, MA, USA.; Gilead Sciences, Foster City, CA, USA., Bradley K; INTREPID Alliance, Cambridge, MA, USA.; Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland., Young JAT; INTREPID Alliance, Cambridge, MA, USA.; Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland., Chandra R; Novartis Pharmaceuticals, East Hanover, NJ, USA., Vaidyanathan S; Novartis Pharmaceuticals, East Hanover, NJ, USA., Chu-Moyer M; Amgen, Thousand Oaks, CA, USA., Lynch CL; AbbVie, North Chicago, IL, USA., Campbell A; AbbVie, North Chicago, IL, USA., Saikatendu KS; Takeda, San Diego, CA, USA., Bilello JP; Gilead Sciences, Foster City, CA, USA., Murata Y; Gilead Sciences, Foster City, CA, USA., van Loock M; Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium., Hurt AC; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Tellinghuisen T; Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland., Ruggiero L; INTREPID Alliance, Cambridge, MA, USA., Mackman R; INTREPID Alliance, Cambridge, MA, USA., Hill NM; INTREPID Alliance, Cambridge, MA, USA., Pottage JC Jr; INTREPID Alliance, Cambridge, MA, USA. john.pottagemd@gmail.com. |
| Corporate Authors: | INTREPID Alliance |
| Source: | Nature reviews. Drug discovery [Nat Rev Drug Discov] 2025 Feb; Vol. 24 (2), pp. 151-152. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784 (Electronic) Linking ISSN: 14741776 NLM ISO Abbreviation: Nat Rev Drug Discov Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39622985 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Antiviral target compound profile for pandemic preparedness. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Demarest+JF%22">Demarest JF</searchLink>; INTREPID Alliance, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Draghia-Akli+R%22">Draghia-Akli R</searchLink>; INTREPID Alliance, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cihlar+T%22">Cihlar T</searchLink>; INTREPID Alliance, Cambridge, MA, USA.; Gilead Sciences, Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bradley+K%22">Bradley K</searchLink>; INTREPID Alliance, Cambridge, MA, USA.; Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Young+JAT%22">Young JAT</searchLink>; INTREPID Alliance, Cambridge, MA, USA.; Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chandra+R%22">Chandra R</searchLink>; Novartis Pharmaceuticals, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Vaidyanathan+S%22">Vaidyanathan S</searchLink>; Novartis Pharmaceuticals, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Chu-Moyer+M%22">Chu-Moyer M</searchLink>; Amgen, Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lynch+CL%22">Lynch CL</searchLink>; AbbVie, North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Campbell+A%22">Campbell A</searchLink>; AbbVie, North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Saikatendu+KS%22">Saikatendu KS</searchLink>; Takeda, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bilello+JP%22">Bilello JP</searchLink>; Gilead Sciences, Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Murata+Y%22">Murata Y</searchLink>; Gilead Sciences, Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22van+Loock+M%22">van Loock M</searchLink>; Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Hurt+AC%22">Hurt AC</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tellinghuisen+T%22">Tellinghuisen T</searchLink>; Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ruggiero+L%22">Ruggiero L</searchLink>; INTREPID Alliance, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mackman+R%22">Mackman R</searchLink>; INTREPID Alliance, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hill+NM%22">Hill NM</searchLink>; INTREPID Alliance, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pottage+JC+Jr%22">Pottage JC Jr</searchLink>; INTREPID Alliance, Cambridge, MA, USA. john.pottagemd@gmail.com. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22INTREPID+Alliance%22">INTREPID Alliance</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101124171%22">Nature reviews. Drug discovery</searchLink> [Nat Rev Drug Discov] 2025 Feb; Vol. 24 (2), pp. 151-152. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101124171 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-1784 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214741776%22">14741776 </searchLink><i>NLM ISO Abbreviation: </i>Nat Rev Drug Discov <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39622985 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41573-024-01102-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 151 Titles: – TitleFull: Antiviral target compound profile for pandemic preparedness. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Demarest JF – PersonEntity: Name: NameFull: Draghia-Akli R – PersonEntity: Name: NameFull: Cihlar T – PersonEntity: Name: NameFull: Bradley K – PersonEntity: Name: NameFull: Young JAT – PersonEntity: Name: NameFull: Chandra R – PersonEntity: Name: NameFull: Vaidyanathan S – PersonEntity: Name: NameFull: Chu-Moyer M – PersonEntity: Name: NameFull: Lynch CL – PersonEntity: Name: NameFull: Campbell A – PersonEntity: Name: NameFull: Saikatendu KS – PersonEntity: Name: NameFull: Bilello JP – PersonEntity: Name: NameFull: Murata Y – PersonEntity: Name: NameFull: van Loock M – PersonEntity: Name: NameFull: Hurt AC – PersonEntity: Name: NameFull: Tellinghuisen T – PersonEntity: Name: NameFull: Ruggiero L – PersonEntity: Name: NameFull: Mackman R – PersonEntity: Name: NameFull: Hill NM – PersonEntity: Name: NameFull: Pottage JC Jr IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2025 Feb Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1474-1784 Numbering: – Type: volume Value: 24 – Type: issue Value: 2 Titles: – TitleFull: Nature reviews. Drug discovery Type: main |
| ResultId | 1 |